Isotretinoin – changes to prescribing guidance and additional risk minimisation measures

2026-01-22T16:15:32+00:00

The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review…